Verastem Stock Price (NASDAQ:VSTM)

Add to My Stocks
$8.65 $0.1 (1.14%) VSTM stock closing price Sep 21, 2018 (Closing)
Prev Close* : $8.75
Market Cap:
$643.93M
Day Low: $8.49
52 Week Low: $2.77
Open: $8.75
Volume: -
Day High: $8.81
52 Week High: $10.35
Dividend:
0.00

Latest Stock Market News

Latest Articles

Verastem News - From Partners

Gelesis Closes $22M Equity Financing   by PRNews on Mar 26, 2015

VSTM Stockcharts

View VSTM PE ratio, PS ratio stocks charts and compare with peers.
VSTM Chart
Note: Compare Verastem stock price history with the index and industry peers.

Verastem Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Verastem Returns

ROE
(return on equity)

Verastem Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

VSTM Industry Peers

Company Price Change (%)
Viking Therapeutics (VKTX)18.20.77 (4.06%)
Kura Oncology (KURA)17.10.1 (0.59%)
Stemline Therapeutics (STML)17.30.3 (1.76%)
Celgene (CELG)87.720.58 (0.66%)
Endocyte (ECYT)17.530.1 (0.57%)
Stemline Therapeutics (STML)17.30.3 (1.76%)
Immunocellular Therapeutics (IMUC)0.20.01 (4.76%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)1.60.13 (8.84%)
BioDelivery Sciences (BDSI)2.850.15 (5.56%)
Acadia Pharma (ACAD)20.171.06 (5.55%)
Trevena (TRVN)1.720.08 (4.88%)
ELOXX PHARMACT (ELOX)16.040.74 (4.84%)
Paratek Pharma (PRTK)9.650.4 (4.32%)
Athersys (ATHX)1.940.08 (4.3%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 21, 2018
CompanyPriceChange (%)
GTx (GTXI)1.821.49 (92.27%)
Uniquire (QURE)38.462.68 (6.51%)
Retrophin (RTRX)27.821.72 (5.82%)
Enzo Biochem (ENZ)4.090.25 (5.76%)
Dicerna Pharma (DRNA)15.990.81 (4.82%)
Innoviva (INVA)14.950.75 (4.78%)
Agenus (AGEN)20.1 (4.76%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 21, 2018

Verastem Inc Stock News - Partner Headlines

Verastem Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-67.8M-36.44M-57.86M-53.36M-41.2M
Total Operating Expense67.8M36.99M58.19M53.59M41.4M
View Verastem income statement
balance sheet20172016201520142013
Total Assets89.79M83.62M113.09M98.64M125.26M
Total Liabilities32.1M11.33M10.62M9.88M7.81M
Shareholders Equity57.68M72.29M102.46M88.76M117.44M
View Verastem balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities4.68M-1.15M2.18M4.98M
Net Cash from (used by) Operating Activities-57.31M-29.48M-45.55M-36.9M-26.3M
Increase (Decrease) in Prop Plant And Equipment--0.03M-0.21M-2.42M-0.05M
View Verastem cash flow statement

Verastem Stock Message Board

As of last trading day, Verastem stock price was $8.65. Looking at Verastem market capitalization, which currently stands at $643.93M, we can say that VSTM stock is a Small Cap stock. Verastem valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy VSTM stock than sell it, then Verastem stock price goes up. Conversely, if more investors wanted to sell VSTM stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 13,141,106 on the last trading day, as is evident from Verastem stock chart, and VSTM stock quote data. Verastem paid 0.00 stock dividends to its shareholders during last quarter. Verastem stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.